AIDSVAX Immunization Induces HIV-specific CD8+ T-cell Responses in High-risk, HIV-negative Volunteers Who Subsequently Acquire HIV Infection

Correlates of immune protection from HIV vaccines remain undefined. The first HIV vaccine efficacy trial in the US and Europe VAX004, was designed to assess whether rgp120 envelope subunits (AIDSVAX B/B, VaxGen) can induce partial or complete protection from HIV-1 infection. No effectiveness in the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jones, Norman G, DeCamp, Allan, Gilbert, Peter, Peterson, Michael L, Gurwith, Marc, Cao, Huyen
Formato: Artigo
Lenguaje:Inglês
Publicado: 2008
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2676722/
https://ncbi.nlm.nih.gov/pubmed/19071176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2008.11.071
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares